Treatment of Epstein-Barr virus-associated lymphoproliferative diseases with Daratumumab

Project Details

Short titleTreatment of Epstein-Barr virus-associated lymphoproliferative diseases with Daratumumab
StatusFinished
Effective start/end date1/07/22 → 30/06/23

Funding

  • Janssen-Cilag Limited